FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma
Diyala Shihadih(University of California, Berkeley), Andreas Stahl(University of California, Berkeley), Daniel K. Nomura(Innovative Genomics Institute), Francesco Urigo(University of Regensburg), Marc K. Hellerstein(University of California, Berkeley), Sharon M. Louie(University of California, Berkeley), Catherine Ward(Stanford University), Peter‐James H. Zushin(Cardiovascular Institute of the South), Xue Wang(University of California, Berkeley), Emily Tso(University of California, Berkeley), Pavlo Khodakivskyi(University of Missouri), Angela Misic(University of California, Berkeley), Diego F. Calvisi(Center for Cancer Research), Jena Shiblak(University of California, Berkeley), Xin Chen(University of California, San Francisco), Elena Goun(Swiss Institute of Comparative Law), Hyo Min Park(University of California, Berkeley)
Cited by 6
Related Papers
Advances in covalent drug discovery
|Nature Reviews Drug Discovery|2022|757
Ubiquitous Activation of Ras and Jak/Stat Pathways in Human HCC
|Gastroenterology|2006|726
Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors
|Proceedings of the National Academy of Sciences|2007|580
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
|Journal of Clinical Investigation|2007|395